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Conclusions 
•Providing longitudinal, individualized, evidence-based approaches to 
tobacco treatment within Cardiology Services is feasible.  
•The modest outcomes from this pilot study support the need for smoking 
cessation treatment provision in hospital Cardiology settings.  
•Such interventions reduce the disproportionate burden of tobacco use and 
related disease among populations with medical co-morbidity 
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• Smoking is a modifiable risk factor for cardiac diseases and also 
worsens the natural history of these conditions. 
• As a result of the addictive nature of tobacco, populations with cardiac 
conditions often continue to smoke at high rates (up to 62%), even after 
experiencing life-threatening cardiac events.  
•Continued smoking by patients with prior or existing cardiac conditions is 
associated with increased risk for subsequent fatal cardiac events. 
•Treating tobacco dependence in these patient populations can 
significantly reduce the excess mortality currently observed. 
• However, few studies in Canada have examined smoking cessation 
outcomes among cardiac patients in outpatient clinic settings.  
•The purpose of our study is to examine pilot treatment outcomes of an 
outpatient Smoking Cessation Clinic (SCC) provided within Cardiology 
Services. 
Background 
Treatment:  The SCC takes a ‘longitudinal’ tobacco treatment approach 
(a process which has no set end-point) in recognition of tobacco 
dependence as a chronic, relapsing medical condition whereby smoking 
cessation is considered “a process and not an event.” The clinic runs 3 
full days a week and is staffed by a team of specialists in tobacco 
dependence treatment comprising of two nurses and a physician. 
Participants are provided with pharmacotherapy and brief individual 
counselling at each clinic visit. In addition, all participants are given 
information for referral to a province-wide telephone “quit line”. 
Treatment completion: Treatment is ongoing until there is mutual 
agreement between the participant and the provider that treatment is 
completed, whether the participant had achieved cessation or not. 
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Methods 
• This study is based on a retrospective review of the charts of 145 
participants of the SCC (between Sept 2010 and May 2012).  
•117 participants engaged in the program (i.e., attended at least one 
follow-up visit beyond the initial visit, see figure 1). 
• Data on demographics, smoking and cessation attempt history, medical 
history (including screening for psychiatric disorders, substance abuse, 
hypertension, high-cholesterol, diabetes, cardiovascular disease, COPD, 
eating disorder, seizure disorder, obesity, kidney disease, asthma, HIV, 
HCV, and cancer), nicotine dependence scores, smoking cessation 
pharmacotherapy, and number of visits to the program (see table 1). 
• The main outcomes of interest were: 1) self-reported 7-day point-
prevalence of smoking abstinence verified by expired CO level, and 2) 
smoking reduction (defined by a 50% or more reduction in average 
number of cigarettes smoked per day compared to baseline). 
  Total 
(N = 117) 
Cardiology 
(n = 93) 
Respirology 
(n = 12) 
Other sources 
(n = 12) 
  N % n % n % n % 
Gender (missing=1)                 
Male  78 66.4 61 66.3 7 58.3 9 75.0 
Female 39 33.6 31 33.7 5 41.7 3 25.0 
History of a psychiatric/substance use disorder                 
Neither 41 34.2 32 34.4 2 16.7 6 50.0 
Psychiatric Disorder Only  24 20.5 19 20.4 1 8.3 4 33.3 
Substance Use Disorder Only  24 20.5 20 21.5 2 16.7 2 16.7 
Both 29 24.8 22 23.7 7 58.3 0 0.0 
Stage of change                  
Precontemplative 4 3.4 4 4.3 0 0.0 0 0.0 
Contemplative 31 26.5 24 25.8 4 33.3 3 25.0 
Preparation 73 62.4 56 60.2 8 66.7 9 75.0 
Action 9 7.7 9 9.7 0 0.0 0 0.0 
Evidence-based modalities used to quit in the  past (i.e., 
NRT, oral medications, counseling) 
92 78.6 72 77.4 11 91.7 9 75.0 
For how long able to quit at last attempt                 
Less than 1 week 25 21.4 20 21.5 3 25.0 2 16.7 
1 week to less than 1 month 17 14.5 15 16.1 1 8.3 1 8.3 
7 months to 1 year 42 35.9 32 34.4 6 50.0 4 33.3 
Greater than 1 year 33 28.2 26 28.0 2 16.7 5 41.7 
Income source (missing=1)                 
Disability/Social Assistance 35 30.2 27 29.3 6 50.0 2 16.7 
Canadian Pension Plan 36 31.0 27 29.3 4 33.3 5 41.7 
Earned Income 45 38.8 38 41.3 2 16.7 5 41.7 
                  
  Mean SD Mean SD Mean SD Mean SD 
Age (years) 58.5 10.5 58.4 9.9 57.1 8.6 60.3 15.6 
Age at smoking initiation (years) 16.4 4.4 16.9 4.6 14.3 2.7 14.1 2.8 
Importance of quitting (on a scale of ‘0’ to ‘10’) 8.6 2.0 8.6 1.9 9.1 1.1 7.6 3.2 
Confidence in quitting (on a scale of ‘0’ to ‘10’) 6.3 2.6 6.4 2.6 7.0 2.4 5.2 2.8 
Average cigarettes smoked per day 15.9 8.0 15.8 7.6 13.3 6.0 19.0 11.9 
FTND at baseline 4.2 2.4 4.2 2.4 4.0 1.7 4.4 2.8 
Expired CO level at baseline 15.8 9.6 15.0 10.2 18.9 5.6 18.3 7.8 
Number of medical co-morbidities 2.8 1.3 2.8 1.3 3.0 1.3 2.4 1.3 
Total visits to programme 5.0 3.3 5.0 3.3 5.3 3.6 4.6 2.9 
Length of time in the programme (in weeks) 19.1 16.2 19.5 16.5 23.4 17.0 11.3 10.3 
Table 1. Characteristics of participants attending a smoking cessation 
programme in cardiology services by referral source 
Results 
• Participants were primarily male (66.4%) and on average were 58.5 years (SD = 
10.5) of age. A greater proportion of individuals referred from Respirology had both 
a history of substance use disorder and mental illness (58.3%) and individuals in 
the Cardiology group initiated smoking at a later age than those in the Respirology 
and “Other” referral source groups (p = .024).  
• 35.0% (41/117) of participants achieved smoking cessation, whereas 42.1% 
(32/76) of those who did not were able to reduce their cigarette use to 50% (or 
less) of their baseline consumption. 
•There was a significant linear trend towards smoking cessation with greater length 
of time in the programme (χ2 = 5.2 [df = 1], p = .023, see figure 2). 
• In multivariate logistic regression analysis, salient predictors of smoking cessation 
included being male (OR= 3.2, 95% CI = 1.0-10.0) and a greater length of time (in 
weeks) in the programme (OR= 1.0, 95% CI = 1.0-1.1).  
Figure 2. Successful smoking cessation outcomes by 
length of time in programme 
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